RYPNX
Price
$20.36
Change
-$0.19 (-0.92%)
Updated
Jul 13 closing price
Net Assets
1.36B
VSIIX
Price
$58.06
Change
-$0.05 (-0.09%)
Updated
Jul 13 closing price
Net Assets
67.78B
Interact to see
Advertisement

RYPNX vs VSIIX

RYPNX vs VSIIX Comparison Chart in %
View a ticker or compare two or three
VS
RYPNX vs. VSIIX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYPNX is a Hold and VSIIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIIX has more cash in the bank: 67.8B vs. RYPNX (1.37B). VSIIX pays higher dividends than RYPNX: VSIIX (1.78) vs RYPNX (0.00). RYPNX was incepted earlier than VSIIX: RYPNX (30 years) vs VSIIX (27 years). RYPNX (1.24) is less costly to investors than VSIIX (0.05). RYPNX is a more actively managed with annual turnover of: 51.00 vs. VSIIX (25.00). RYPNX has a lower initial minimum investment than VSIIX: RYPNX (2000) vs VSIIX (5000000). RYPNX annual gain was more profitable for investors over the last year : 30.35 vs. VSIIX (20.77). VSIIX return over 5 years is better than : 45.96 vs. RYPNX (1.80).
RYPNXVSIIXRYPNX / VSIIX
Total Expense Ratio1.240.052,480%
Annual Report Gross Expense Ratio1.240.052,480%
Fund Existence30 years27 years-
Gain YTD28.37314.485196%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B67.8B2%
Annual Yield % from dividends0.001.78-
Returns for 1 year30.3520.77146%
Returns for 3 years35.0145.8776%
Returns for 5 years1.8045.964%
Returns for 10 years74.76132.0457%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
VGSIX32.36N/A
N/A
Vanguard Real Estate Index Investor
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6